NOV 15, 2016 9:00 AM PST

Antigen-specific, poly-functional CD4+ T cells are required for vaccine-mediated protection in tularemia

Speaker
  • Rocky Mountain Laboratories, NIAID, NIH
    Biography
      Dr. Lydia Roberts received her undergraduate degrees in Chemistry and Biochemistry from Kansas State University in 2008 followed by her PhD in Microbiology and Immunology in 2013 from the University of North Carolina- Chapel Hill. Dr. Roberts is currently a post-doctoral fellow in the laboratory of Dr. Catharine Bosio at Rocky Mountain Laboratories, NIAID, NIH.

    Abstract
    DATE: November 15, 2016
    TIME: 9:00 AM PT, 12:00 PM ET


    The virulent intracellular pathogen Francisella tularensis subsp. tularensis (Ftt) causes an acute, lethal disease called tularemia. Surviving tularemia depends on the presence of an effective adaptive immune response. However, the nature of such a response has not been elucidated. Thus, we designed in vitro and in vivo models to characterize the protective immune responses with the goal of applying these features to novel vaccines. Utilizing unlicensed vaccine strains with varying efficacy, we found that vaccinated mice lacking CD4+ T cells succumbed rapidly to Ftt challenge, surviving only 1 day longer than naïve animals. These data indicated that vaccine-mediated protection requires a pool of CD4+ T cells capable of immediately controlling Ftt replication. We found effective vaccination correlated with the presence of poly-functional CD4+ T cells producing IFN-γ, TNF-α, and IL-2 and these purified pulmonary and splenic CD4+ T cells controlled Ftt replication in vitro. To follow the antigen-specific response, we generated vaccine and Ftt strains expressing the well-characterized epitope gp61 from LCMV. Immune animals had persistent numbers of gp61-specific CD4+ T cells in their lymph nodes and spleens, whereas vaccinated, but non-immune animals did not. Therefore, we hypothesized the expansion of high avidity, antigen specific CD4+ T cells would convert a poorly efficacious vaccine to one that engenders protection. As predicted, inclusion of the gp61 epitope in both the vaccinating strain and virulent Ftt challenge strain converted a vaccine that failed evoke adequate T cell responses to one that was 100% protective. Together our work has revealed successful vaccines directed against an aggressive, highly pathogenic organism requires a large pool of high avidity, poly-functional CD4+ T cells. Moreover, the elucidation of Francisella epitopes that elicit high-avidity CD4+ T cell responses, specifically in humans, will be required for successful vaccine development

    Learning Objective 1: Learn about in vitro and in vivo immune response models to Francisella                                                 tularensis subsp. tularensis (Ftt) infection.

    Learning Objective 2: Learn how effective vaccination correlates with the presence of poly-                                                       functional CD4+ T cells.
     

    Show Resources
    You May Also Like
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    Loading Comments...
    Show Resources
    Attendees
    • See more